Back to video list Back to Home Prof Goadsby, can you comment on the dosing schedule of eptinezumab? Does it differ from episodic to chronic migraine patients? Migraine with or without aura? You may also like Parkinson's Disease Article Approaches for better management of Parkinson’s disease Parkinson's Disease Congress highlights Article Parkinson’s disease – early detection and risk stratification Depression Article Ketamine metabolite may hold a key to novel antidepressants Schizophrenia Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden